New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The investigators found no benefit from magnesium treatment compared with placebo.

"The findings from MASH 2 have important implications for clinical practice. Administration of magnesium is standard practice in many centres", explains Sanne Dorhout Mees from University Medical Center Utrecht, Netherlands, who led the research.

About a third of with aneurysmal subarachnoid haemorrhage (SAH; the bursting of a blood vessel on the surface of the brain), the deadliest form of stroke, will die within the first month. Of those that survive, 20% are left disabled. Delayed cerebral ischaemia can occur 4 to 10 days after SAH and is an important cause of poor outcome.

The benefits of intravenous magnesium sulphate to limit the damage from SAH are controversial. Despite promising findings from earlier research, more recent studies have reported conflicting results.

Here, the report the results of a comparing magnesium treatment (606 patients) with placebo (saline; 597 patients) in adults with SAH from the Netherlands, Scotland, and Chile. The main outcome measure was poor outcome defined as a score of 4 to 5 on the modified Rankin Scale (meaning severe disability), or death, 3 months after haemorrhage.

No difference in poor outcome was recorded between the groups at 3 months—158 patients (26.2%) given magnesium compared with 151 (25.3%) given placebo had poor outcome.

A further meta-analysis of seven randomised trials involving over 2000 patients with SAH found magnesium was not superior to placebo.

The authors conclude: "Results from MASH 2 alone, and in combination with the other trial data, show that intravenous magnesium does not affect outcome after aneurysmal subarachnoid haemorrhage. Subgroup analyses did not identify a subgroup of patients who might benefit from magnesium treatment…therefore routine administration of magnesium cannot be recommended."

In a linked Comment, Chethan Venkatasubba Rao and Jose Suarez from Baylor College of Medicine, Texas, USA remark: "The results, although disappointing, are nonetheless very pertinent to the management of patients with aneurysmal subarachnoid haemorrhage. We agree with the researchers, and previous findings, that routine intravenous magnesium sulphate infusion cannot be recommended for patients with aneurysmal subarachnoid haemorrhage."

More information: Paper online: www.thelancet.com/journals/lan… (12)60724-7/abstract

add to favorites email to friend print save as pdf

Related Stories

Preterm birth: Magnesium sulphate cuts cerebral palsy risk

Jan 21, 2009

Magnesium sulphate protects very premature babies from cerebral palsy, a new study shows. The findings of this Cochrane Review could help reduce incidence of the disabling condition, which currently affects around one in ...

Recommended for you

Barriers preventing post-stroke care

19 hours ago

For stroke victims, rehabilitation is crucial to their recovery. But a Flinders University study conducted in Singapore found that rehabilitation rates following discharge from hospital are poor because of gaps in the continuum ...

Home-based rehabilitation for CVD patients

19 hours ago

Patients who are found to suffer from cardiovascular diseases often have long years of treatment ahead of them and are urged to drastically change their lifestyle. But what is probably the most difficult ...

New remote patient monitoring devices available

23 hours ago

(HealthDay)—Several new remote patient monitoring devices with useful applications are available or under development, according to an article published July 8 in Medical Economics.

Monitoring pulse after stroke may prevent a second stroke

Jul 23, 2014

New research suggests that regularly monitoring your pulse after a stroke or the pulse of a loved one who has experienced a stroke may be a simple and effective first step in detecting irregular heartbeat, a major cause of ...

User comments